Trial intelligence / Profile preview

Metformin XR in Chinese Patients with Newly Diagnosed Type 2 Diabetes

NCT00778622Phase 4Completed

Sponsor
Bristol Myers Squibb
Start
Nov 2009
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of liquid metformin (Aspargo Labs) in type 2 diabetes mellitus (T2DM), sponsored by Bristol Myers Squibb. Started Nov 2009; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00778622.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00778622.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call